https://crisprcas9receptor.com..../index.php/pathophys
An improved understanding of the metabolic part of GPCRs in hepatocytes, the dominant constituent cells for the liver, could lead to the development of novel medications that are clinically helpful for the treatment of numerous metabolic diseases, including diabetes, nonalcoholic fatty liver infection (NAFLD) and nonalcoholic steatohepatitis (NASH). In this review, we describe the functions of several GPCRs expressed in hepatoc
Like
Comment
Share
